[1]
Blackhouse, G. et al. 2018. CANADIAN COST-UTILITY ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN FOR ACUTE CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA. Journal of Population Therapeutics and Clinical Pharmacology. 19, 2 (Nov. 2018).